My recent PRP post sparked some critical comments. Good. That is exactly what scientific discussion should do. But there is one rather inconvenient aspect of the PRP literature that deserves more attention. When searching registered trials of platelet-rich plasma for osteoarthritis that were started before 2020, the overwhelming majority appear to have no publicly available […]
